The anti-breast cancer potential of indole/isatin hybrids.
Arch Pharm (Weinheim)
; 356(11): e2300402, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37650315
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Isatin
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Arch Pharm (Weinheim)
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Germany